Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michiel H, Strijbos"'
Publikováno v:
ESMO Open
In the past decade, several agents targeting angiogenesis and signal transduction pathways have replaced the use of cytokines as standard of care treatment for metastatic renal cell carcinoma (RCC) after showing improved clinical benefit and survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a609218b05f0b47ad1da7ed22354a0a7
http://hdl.handle.net/10230/33562
http://hdl.handle.net/10230/33562
Publikováno v:
ESMO Open
During the last decade, the treatment of advanced or metastatic renal cell carcinoma (RCC) was revolutionised with the advent of antiangiogenic drugs and tyrosine-kinase inhibitors. Several agents targeting the vascular endothelial growth factor (VEG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cddc08bb21bf254b55e1f5ec3e2d2d4
https://doi.org/10.1136/esmoopen-2017-000185
https://doi.org/10.1136/esmoopen-2017-000185
Autor:
Michiel H, Strijbos, Chandra, Rao, Paul I M, Schmitz, Jaco, Kraan, Cor H, Lamers, Stefan, Sleijfer, Leon W M M, Terstappen, Jan W, Gratama
Publikováno v:
Thrombosis and haemostasis. 100(4)
Increased numbers of circulating endothelial cells (CEC) in peripheral blood have been observed in diseases with vascular involvement, and are considered a promising surrogate marker for vascular damage. It was the objective of this study to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7db4663cb888a01cbecabb547619ac93
https://pubmed.ncbi.nlm.nih.gov/18841287
https://pubmed.ncbi.nlm.nih.gov/18841287